Journey Medical targets sustained EMROSI momentum and profitability through 2025 as prescriber base nearly triples Journey Medical targets sustained EMROSI momentum and profitability through 2025 as prescriber base nearly triples Post ContentdermRead More You might also be interested in reading Highlights from Cognisphere Twitter. August 12, 2025 In Mainstream ← Previous post Next post →